This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.
Tag: prostate cancer
GlycoNet scientist discusses novel biomarkers that aim to revolutionize care for prostate cancer patients
By Anushka Jayasuriya & Chardelle Prevatt – June 23, 2017 Prostate cancer, the most commonly diagnosed cancer in Canadian men, is currently screened using the prostate-specific antigen (PSA) serum test. However, in 30% of cases, PSA is elevated for reasons other than prostate cancer; as a result, prostate cancer is also the most over-treated cancer. […]